Liberelle

Ethinylestradiol, the active ingredient in Liberelle, is a combined oral contraceptive presented as an oral tablet for oral use. It prevents pregnancy in women of reproductive age by inhibiting ovulation and altering cervical mucus and endometrial lining. GNH USA supplies Liberelle as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Liberelle, a combined oral contraceptive, is used to prevent unintended pregnancy. - Prevention of pregnancy: provides reliable contraception for women of childbearing potential.

Common side effects are generally mild and transient.

Common Side Effects: - Nausea: mild stomach upset, especially when starting therapy. - Headache: tension‑type or migraine‑like pain. - Breast tenderness: temporary swelling or discomfort. - Spotting or breakthrough bleeding: irregular bleeding during the first cycles. - Mood changes: irritability or mild mood swings. - Weight fluctuation: slight fluid retention or appetite changes.

Serious or Rare Side Effects: - Venous thromboembolism: deep‑vein thrombosis or pulmonary embolism. - Arterial thrombosis: stroke or myocardial infarction. - Hypertension: significant increase in blood pressure. - Liver dysfunction: jaundice or abnormal liver enzymes. - Gallbladder disease: gallstones or cholecystitis. - Severe allergic reaction: rash, swelling, or anaphylaxis.

Before using Liberelle, consider the following precautions. - Smoking: avoid if over 35 years old, as risk of cardiovascular events increases. - Cardiovascular disease: contraindicated in patients with history of thromboembolism, stroke, or myocardial infarction. - Liver disease: use with caution in patients with active liver disease or impaired function. - Migraine with aura: contraindicated due to elevated stroke risk. - Breast cancer: avoid in current or past estrogen‑dependent malignancies. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Liberelle may interact with several medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - Antiepileptic drugs (e.g., carbamazepine, phenytoin): reduce contraceptive efficacy. - Rifampin and other potent enzyme inducers: markedly decrease hormone levels. - Certain HIV protease inhibitors: may increase hormone concentrations.

Moderate Interactions (Monitor Closely): - Antifungal agents (e.g., ketoconazole): may increase hormone levels. - St. John’s wort: may lower contraceptive effectiveness. - Certain antibiotics (e.g., tetracycline): occasional reduction in efficacy, monitor for breakthrough bleeding.